AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New developments in drug-eluting stents, heart failure management.(Editorial)
April 1, 2005... New developments in drug-eluting stents, heart failure management
By MICHAEL SIMONSEN, PhD
CDU Contributing Editor
ORLANDO, Florida - The annual conference of the American College of Cardiology (ACC, Bethesda, Maryland), held here...
Range of device and drug-related work on ACC's radar screen.(American College of Cardiology)(Editorial)
April 1, 2005... Range of device and drug-related work on ACC's radar screen
By DON LONG
CDU Managing Editor
ORLANDO, Florida - Cardiovascular Device Update, quite obviously, focuses on devices and instrumentation used in the cardiovascular field,...
Companies showcase products and services.
April 1, 2005... ACC notebook
Companies showcase products and services
A CDU Staff Report
ORLANDO, Florida - A wide variety of companies rolled out an even wider variety of new products and services on the Orange County Convention Center exhibit...
Coronavirus may have pediatric heart ties.
April 1, 2005... From the lab
Coronavirus may have pediatric heart ties
By ANETTE BREINDL
CDU Science Editor
Emerging Asian viruses get a lot of attention, be they severe acute respiratory syndrome or fresh flu strains. But new, or at last...
International report.
April 1, 2005... International report
ELA releases second version of Symphony
A CDU Staff Report
Cardiac rhythm management company ELA Medical (Monrouge, France) last month reported the European release of Symphony AAIsafeR 2, its...
Acquisitions.
April 1, 2005... Acquisitions
* Cardiac Science (Irvine, California), a maker of automatic public-access automated external defibrillators (AEDs), reported last month that it plans to merge with Quinton Cardiology Systems (Bothell, Washington) in order to...
Business developments.
April 1, 2005... Business developments
GenVec, Cordis launch BioBypass Phase IIB
GenVec (Gaithersburg, Maryland) last month reported the launch of a Phase IIB randomized, placebo-controlled trial of its BioBypass angiogen for the treatment of severe...
Agreements.
April 1, 2005... Agreements
* Alliance Medical (Phoenix), a reprocessor of single-use medical devices (SUDs), reported that Premier Purchasing Partners (San Diego), has signed a three-year agreement with the company to offer medical device reprocessing...
Market Updates.
April 1, 2005... Market Updates
Carotid stent coverage is evidence-based
While many major headlines over the past month have tracked President George Bush's proposed plan to stave off the bankruptcy of the Social Security system, continued bankrolling...
Reporter's death sparks DVT awareness.(deep-vein thrombosis)
April 1, 2005... Reporter's death sparks DVT awareness
U.S. senators unanimously passed a resolution early last month in an effort to raise awareness concerning deep-vein thrombosis (DVT). The passage of Senate Resolution 56, co-sponsored by Arlen Specter...
Personnel File.(Brief Article)
April 1, 2005... Personnel File
* David Phillips has been appointed vice president of marketing for HemoSense (San Jose, California), responsible for developing marketing initiatives in support of the company's INRatio Prothrombin Time Monitoring System, a...
Product Pipeline.
April 1, 2005... Product Pipeline
Thoratec gets OK for Heartmate II IDE trial
In what could be seen as a coup, ventricular assist device maker Thoratec (Pleasanton, California) reported last month that the FDA granted it a virtually condition-free...